This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2023 Sep 20;41(27):4321-4322.

doi: 10.1200/JCO.22.02860.

Flashback Foreword: Prognostic Factors in Osteosarcoma

Robert G Maki^{1

2

3}, Gary K Schwartz^{1

4

5}

Affiliations

Affiliations

¹ Associate Editor, Journal of Clinical Oncology, Alexandria, VA.
² University of Pennsylvania, Perelman School of Medicine, Abramson Cancer Center, Philadelphia, PA.
³ Memorial Sloan-Kettering Cancer Center, New York, NY.
⁴ Columbia University, Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, New York, NY.
⁵ Case Comprehensive Cancer Center, Cleveland, OH.

PMID: 37713811
DOI: 10.1200/JCO.22.02860

Editorial

Flashback Foreword: Prognostic Factors in Osteosarcoma

Robert G Maki et al. J Clin Oncol. 2023.

. 2023 Sep 20;41(27):4321-4322.

doi: 10.1200/JCO.22.02860.

Authors

Robert G Maki^{1

2

3}, Gary K Schwartz^{1

4

5}

Affiliations

¹ Associate Editor, Journal of Clinical Oncology, Alexandria, VA.
² University of Pennsylvania, Perelman School of Medicine, Abramson Cancer Center, Philadelphia, PA.
³ Memorial Sloan-Kettering Cancer Center, New York, NY.
⁴ Columbia University, Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, New York, NY.
⁵ Case Comprehensive Cancer Center, Cleveland, OH.

PMID: 37713811
DOI: 10.1200/JCO.22.02860

No abstract available

PubMed Disclaimer

Similar articles

Prognostic value of P-glycoprotein in high-grade osteosarcoma.
Serra M, Picci P, Ferrari S, Bacci G. Serra M, et al. J Clin Oncol. 2007 Oct 20;25(30):4858-60; author reply 4860-1. doi: 10.1200/JCO.2007.13.0534. J Clin Oncol. 2007. PMID: 17947741 No abstract available.
Osteosarcoma.
Whelan JS. Whelan JS. Eur J Cancer. 1997 Sep;33(10):1611-8; discussion 1618-9. doi: 10.1016/s0959-8049(97)00251-7. Eur J Cancer. 1997. PMID: 9389923 Review. No abstract available.
Osteosarcoma.
McLaughlin RE, Sweet DE. McLaughlin RE, et al. Va Med Mon (1918). 1973 Apr;100(4):357-62 passim. Va Med Mon (1918). 1973. PMID: 4511807 No abstract available.
[Therapy and prognosis in osteosarcoma: changing thoughts and numbers].
Campanacci M. Campanacci M. Chir Organi Mov. 1984 Jan-Mar;69(1):7-9. Chir Organi Mov. 1984. PMID: 6593179 Italian. No abstract available.
Osteosarcoma.
Meyers PA, Gorlick R. Meyers PA, et al. Pediatr Clin North Am. 1997 Aug;44(4):973-89. doi: 10.1016/s0031-3955(05)70540-x. Pediatr Clin North Am. 1997. PMID: 9286295 Review.

See all similar articles

Cited by

Prognostic and predictive value of super-enhancer-derived signatures for survival and lung metastasis in osteosarcoma.
Huang G, Zhang X, Xu Y, Chen S, Cao Q, Liu W, Fu Y, Jia Q, Shen J, Yin J, Zhang J. Huang G, et al. J Transl Med. 2024 Jan 22;22(1):88. doi: 10.1186/s12967-024-04902-8. J Transl Med. 2024. PMID: 38254188 Free PMC article.
Exosomes derived from FN14-overexpressing BMSCs activate the NF-κB signaling pathway to induce PANoptosis in osteosarcoma.
Wang L, Huang Y, Zhang X, Chen W, Dai Z. Wang L, et al. Apoptosis. 2025 Apr;30(3-4):880-893. doi: 10.1007/s10495-024-02071-z. Epub 2025 Jan 20. Apoptosis. 2025. PMID: 39833632 Free PMC article.
Integrative single-cell and bulk RNA-seq analysis identifies lactylation-related signature in osteosarcoma.
Xie Z, Qu X, Zhang J, Huang Y, Runhan Z, Tang D, Li N, Wang Z, Luo X. Xie Z, et al. Funct Integr Genomics. 2025 Mar 12;25(1):60. doi: 10.1007/s10142-025-01559-4. Funct Integr Genomics. 2025. PMID: 40072643
Exosomal Gene Biomarkers in Osteosarcoma: Mifepristone as a Targeted Therapeutic Revealed by Multi-Omics Analysis.
Li Z, Guo J, Zhu S, Zou Y, Ma W, Niu J, Liu R, Zhao K. Li Z, et al. FASEB J. 2025 Jul 15;39(13):e70809. doi: 10.1096/fj.202501151RR. FASEB J. 2025. PMID: 40616392 Free PMC article.
CAFs exosomal miR-21-5p suppresses ferroptosis and promotes proliferation and migration in osteosarcoma.
Niu X, Tian W, Ke Y, Li Y, Zhang X. Niu X, et al. Cancer Cell Int. 2025 Aug 19;25(1):308. doi: 10.1186/s12935-025-03930-8. Cancer Cell Int. 2025. PMID: 40826086 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information